Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Portfolio Pulse from Benzinga Insights
Over the past 20 years, Regeneron Pharmaceuticals (NASDAQ:REGN) has delivered an average annual return of 23.61%, outperforming the market by 15.65% annually. A $1000 investment in REGN 20 years ago would be worth $68,524.79 today. The company's market capitalization currently stands at $106.20 billion.
March 08, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals has shown remarkable growth over the past 20 years, with a $1000 investment growing to $68,524.79, reflecting an average annual return of 23.61%.
The significant long-term growth of Regeneron Pharmaceuticals, as highlighted by the 20-year performance data, underscores the company's strong market position and potential for continued growth. This historical performance, especially the impressive return on investment, is likely to positively influence investor sentiment and potentially drive short-term interest and investment in REGN stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100